GaraHerb Supplement Facts, Ingredient Label Details, and Product Disclosures: A 2026 Informational Overview of Male Enhancement Supplement Options
New York, NY, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article…
Cannabix Technologies announces Non-Brokered LIFE Private Placement
February 06, 2026 19:00 ET | Source: Cannabix Technologies Inc. NOT FOR…
LuminEye Nano-Drops Product Information Updated as Consumer Interest in Eye Health Supplement Options and Vision Support Alternatives Grows in 2026
New York, NY, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article…
Mawson Infrastructure Group Inc. Releases Preliminary Unaudited Results for Fourth Quarter and Fiscal Year 2025
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large…
7/2026Trifork Group: Share-Based Incentive Program 2026
Company announcement no. 7 / 2026 Schindellegi, Switzerland – 6 February 2026…
Notice to convene the Annual General Meeting 2026
Company announcement No. 11/2025 6 February 2026 Notice to convene the…
HUTCHMED to Announce 2025 Final Results
February 06, 2026 03:30 ET | Source: HUTCHMED (China) Limited HONG KONG…
VALNEVA Declaration of shares and voting rights: January 31, 2026
VALNEVA Declaration of shares and voting rights January 31, 2026__________________________________________________________________________________________ Company name:…
Coloplast A/S – Interim Financial Report, Q1 2025/26
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast…
Pluristyx and Solesis Launch First-of-its-Kind PluriForm-GFP-3D Transfection Kit, Solving Critical Bottlenecks in Suspension Culture Transfection
New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with…
